熱門資訊> 正文

Sonoma Pharmaceuticals公布第一季度业绩

2025-08-08 05:55

Sonoma Pharmaceuticals press release (NASDAQ:SNOA): Q1 revenue of $4.01M misses by $0.04M.
Net loss for the quarter of $1.2 million was nearly flat when compared to a net loss of $1.1 million for the quarter ended June 30, 2024.
As of June 30, 2025, Sonoma had cash and cash equivalents of $3.6 million.

More on Sonoma Pharmaceuticals

Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals
Historical earnings data for Sonoma Pharmaceuticals
Financial information for Sonoma Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。